In my opinion, the share price range you quoted is totally possible. If prit. can demonstrate it's effectiveness in cancer patients this company won't get past Phase II testing and it will be acquired. Ultimately, I believe that to be management's goal. But these are my opinions only. Best of luck to the longs./ok2